Cargando…
Azilsartan protects against hyperglycemia-induced hyperpermeability of the blood-brain barrier
Diabetes mellitus (DM) is a complex metabolic disease with significant neurological complications and is reported to be closely related to the blood-brain barrier (BBB) disruption. Azilsartan is an antagonist of the Angiotensin II receptor developed for the treatment of hypertension, and it has been...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806574/ https://www.ncbi.nlm.nih.gov/pubmed/34266350 http://dx.doi.org/10.1080/21655979.2021.1948950 |